BiomedicineNews.net

Biomedicine Xagena

Xagena Mappa
Medical Meeting
Reumabase.it
Neurobase.it

Anticancer response: multistep process in which proteins interact with NKG2D on NK cells identified


Researchers at Mayo Clinic have identified and characterized an important signal used by the human immune system to help destroy tumors. When this signal is generated inside cells called natural killer ( NK ) cells, materials are released in the body that induce cell death in cancer cells.

The report is published in the Nature Immunology.

Natural killer cells are blood cells that have an innate ability to kill tumor cells and virus-infected cells. For example, when an NK cell encounters a new tumor developing, it may generate signals that will kill the tumor and clear it from the body. However, depending on the signals it receives, it may also communicate the opposite message -- and promote disease -- by generating signals that block the destruction of tumors or viruses.

While researchers have known that NK cells play key roles in fighting cancer, no one has known precisely how the NK cells initiate these varied tasks. The Mayo Clinic work clarifies this by identifying the biochemical players and their role in activating the toxic response against tumor cells and viruses.

The Mayo Clinic team discovered a multistep process in which the proteins DAP10, PI-3K and Grb2 must interact with a structure on NK cells called NKG2D. Once that happens, NKG2D can initiate a toxic anticancer response.

" Because NK cells can communicate different messages -- one that serves health by clearing tumors and viruses and one that serves disease by blocking the response to cancer -- understanding which signals result in effective tumor clearance is a high priority for those of us fighting cancer," explains Paul Leibson, at Mayo Clinic.

Source: Mayo Clinic, 2006


XagenaMedicine_2006



Indietro